Skip to Content
Resources

Aligning data resources to drive drug management and decision-making

Sponsored White Paper

From PBMs and payers, to prescribers and pharmacies, Medi-Span® helps all players work from consistent drug and pricing data to advance safety.

Presented By

Wolters Kluwer

Document Info

Published on Aug 14, 2024

Download and read the full Resource.

Resource Details

Disclaimer

This white paper represents the views of the author, not America’s Health Insurance Plans (AHIP). The publication, distribution or posting of this white paper by AHIP does not constitute a guaranty of any product or service by AHIP.

The drug benefit is one of the most important to those selecting an insurance plan.

The U.S. Department of Health and Human Services estimates 84% of the American population is covered by prescription drug insurance.¹ And health plan members are taking advantage of their drug benefits. In 2022, according to Statista, there were more than 6.7 million medical prescriptions dispensed in the U.S.²

For those behind critical decisions regarding drug management, prescribing, and dispensing, these interactions are becoming increasingly challenging as the volume of new drugs, consumers, transactions, and the speed and complexity of healthcare business increases. In order to keep patients and members safe without sacrificing efficiency or profit, healthcare businesses need to have consistent drug data to help streamline and align communication and information-sharing between partners.